soilDBdata
soilDBdata exists so soilDB's tests can run without a NASIS connection.
A side-by-side editorial comparison of b3gbi and medsim — release velocity, themes, recent moves, and the top alternatives to consider.
b3gbi pulled confidence intervals out of its indicator workflow and handed them to dubicube.
b3gbi computes biodiversity indicators from GBIF occurrence cubes for the B-Cubed project, and sits at 0.9.4 in a JOSS review run-up. The 0.9 release decoupled uncertainty from indicator calculation: confidence intervals are no longer produced inline but added afterward with add_ci(), backed by whole-cube bootstrapping from the sibling dubicube package. Everything since has been grid-parsing and compatibility repair around that split.
medsim is turning simulation runs into auditable artifacts, not just fast ones.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
b3gbi computes biodiversity indicators from GBIF occurrence cubes for the B-Cubed project, and sits at 0.9.4 in a JOSS review run-up. The 0.9 release decoupled uncertainty from indicator calculation: confidence intervals are no longer produced inline but added afterward with add_ci(), backed by whole-cube bootstrapping from the sibling dubicube package. Everything since has been grid-parsing and compatibility repair around that split.
Two forces are shaping releases. Internally, the uncertainty split produced an indicator-specific rule book — species-level indicators bootstrap the whole cube, raw counts resample within year, evenness gets a logit transform — and that rule book is where the statistical thinking now lives. Externally, GBIF's taxonomic backbone migration to the Catalogue of Life forced string taxon keys through process_cube() and the plotting paths, while recurring EEA and MGRS grid-code fixes mark coordinate parsing as the least settled area.
The 0.9.4 notes are entirely JOSS review items — contributors, examples, tracked datasets — so the next release is most likely a JOSS-accepted 1.0 rather than new indicator work.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.
The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either b3gbi or medsim.
soilDBdata exists so soilDB's tests can run without a NASIS connection.
collinear has broken its API twice to stop making the user pick thresholds.
nert put fourteen TERN datasets behind one dispatcher and called it stable.
scTypeEval judges single-cell annotations without needing a ground truth to judge them against.
medrobust made its partial-identification bounds usable by giving them confidence intervals.
probmed went from one probabilistic effect size to a family of them in sixteen days.
See all b3gbi alternatives → · See all medsim alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — r package — within Analytics. medsim is currently shipping more aggressively (velocity 6.3 vs 2.5), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim is currently shipping more aggressively (velocity 6.3 vs 2.5), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top b3gbi alternatives in Analytics are ranked by recent ship velocity. Browse the "b3gbi alternatives" section above for the current picks, or visit /alternatives/b3gbi for the full list with editorial commentary on each.
Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.